CClinicalTrials.gg
RecruitingNCT07629141Updated Jul 1, 2026

Muscle Position and Dry Needling Efficacy

An interventional study of Dry needling technique with the shoulder in full adduction. and Dry needling technique with the shoulder in 90° abduction. in Neck Pain and Headache, sponsored by University of Alcala. Recruiting at 2 sites in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by University of Alcala · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Currently, no previous studies have investigated how the position of a muscle before dry needling may influence the outcome and effectiveness of the treatment.

This study aims to demonstrate whether the position of the upper trapezius muscle during dry needling treatment influences the outcome of that treatment in subjects with neck pain.

A total of 46 participants with chronic neck pain will be recruited and randomly assigned to two groups: a dry needling group with the muscle in a stretched position and a dry needling group with the muscle in a shortened position. A total of two treatment sessions will be performed, separated by a 7-day interval. The primary outcome measure will be the intensity of neck and head pain, measured using the visual analog scale (VAS). Other variables to be measured include the cervical disability index, kinesiophobia, and catastrophizing (using a self-completion questionnaire), as well as participants' expectations and post-needling pain.

02

Conditions studied

  • Neck Pain
  • Headache

Keywords

  • dry needling
  • Musculoskeletal Pain
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 65 years
  • Neck pain lasting more than 3 months
  • Current neck pain greater than 3/10 on the VAS (Visual Analog Scale)
  • Presence of active trigger points in the upper trapezius muscle, meeting the following criteria: Painful point within a taut band whose palpation reproduces the patient's symptoms.

Exclusion criteria

Exclusion Criteria:

  • Neck pain with a medical diagnosis (fractures, arthritis, fibromyalgia, etc.)
  • Radicular pain (paresthesia, burning, electric shocks)
  • Whiplash or any recent trauma
  • Previous surgery
  • Treatment by another physiotherapist within the last 3 months
  • Infections
  • Needle phobia
  • Use of anticoagulant medications
  • Pregnancy
  • Fibromyalgia
  • Metal allergies
  • Cognitive deficits or communication problems
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Upper trapezius dry needling with adduction shoulder

    The dry needling technique will be applied to the trapezius muscle while the subject lies prone, with the upper limb at the side of the body, shoulder lowered, in adduction and cervical region in a neutral position. The dry needling technique will be applied using a pincer grasp, inserting the needle from the posterior to the anterior portion of the upper trapezius muscle.

    Other: Dry needling technique with the shoulder in full adduction.

  • Experimental
    Upper trapezius dry needling with 90º abduction shoulder

    The dry needling technique will be applied to the trapezius muscle while the subject lies prone, with the upper limb separated from the body, shoulder at 90 degrees of abduction and cervical region in a neutral position. The dry needling technique will be applied using a pincer grasp, inserting the needle from the posterior to the anterior portion of the upper trapezius muscle.

    Other: Dry needling technique with the shoulder in 90° abduction.

Interventions

  • OtherDry needling technique with the shoulder in full adduction.

    Ten incisions will be made in a posteroanterior direction while the patient lies prone and the muscle is grasped with a pincer grip between the first three fingers. The technique will be applied to the area that is mechanically most hyperalgesic and related to the reproduction of the patient's pain.

  • OtherDry needling technique with the shoulder in 90° abduction.

    Ten incisions will be made in a posteroanterior direction while the patient lies prone and the muscle is grasped with a pincer grip between the first three fingers. The technique will be applied to the area that is mechanically most hyperalgesic and related to the reproduction of the patient's pain.

05

What researchers measure

Primary outcomes

  1. The visual analog scale (VAS)

    Intensity of neck and head pain: This was measured using the visual analog scale (VAS). It consists of a 10 cm horizontal line, where 0 cm on the left side represents "no pain" and 10 cm on the right side represents "maximum pain." The subject marks a perpendicular line at the point they consider to represent their pain intensity. The examiner then places a millimeter ruler on the scale, assigning a numerical value to the line drawn by the patient. The VAS has proven to be a valid and reliable tool (intraclass correlation coefficient \[ICC\] 0.71-0.99).

    Time frame: Change from baseline at 3 months

Secondary outcomes

  1. Disability Associated with Neck Pain

    The degree of disability associated with neck pain will be measured using the Neck Disability Index (NDI) questionnaire in its Spanish version. The NDI is a 10-item questionnaire, and each item is scored on a scale of 0 to 5 points, with a range of 0 to 50 points. The higher the score, the greater the degree of disability. The NDI has proven to be a reliable tool (ICC 0.98).

    Time frame: Change from baseline at 3 months

  2. Kinesiophobia with the Tampa Kinesiophobia Scale (TSK-11)

    The Tampa Kinesiophobia Scale (TSK-11) short version will be used to assess fear of movement. It is an 11-item scale rated on a four-point scale ranging from "strongly agree" to "strongly disagree." Scores range from 11 to 44, with higher scores indicating greater fear of movement and/or (re)injury. This questionnaire has demonstrated similar properties to the original TSK scale, proving to be a valid and reliable instrument.

    Time frame: Change from baseline at 3 months

  3. Catastrophizing with the Pain Catastrophizing Scale (PCS)

    Catastrophizing Scale (PCS). The PCS has 13 items scored from 0 to 4 and is composed of three subscales: rumination, magnification, and helplessness. The overall score ranges from 0 to 52. Higher scores indicate a greater degree of pain catastrophizing. A total score \>30 represents a clinically significant level of pain catastrophizing. This questionnaire has been shown to be reliable (ICC 0.94).

    Time frame: Change from baseline at 3 months

  4. Local twitch response (LTRs)

    Local twitch response (LTRs). The LTRs produced by needle insertion during dry needling will be counted. LTRs are generally associated with better treatment outcomes. A higher number of LTRs indicates better results, and a lower number of LTRs indicates worse results.

    Time frame: Change from baseline at 3 months

  5. Cervical joint Range

    Flexion, inclination, extension and rotational movement ranges will be measured with a cervical goniometer

    Time frame: Change from baseline mobility at one week after intervention

06

Study locations

2 of 2 sites recruiting
  • Clinical University Physiotherapy and pain
    Alcalá de Henares, Madrid 2805, Spain
    Recruiting
  • Physioterapy and Pain center research
    Alcalá de Henares, Madrid 28805, Spain
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07629141
Lead sponsor
University of Alcala
Responsible party
Prof. Dr. Daniel Pecos Martín (Profesor, University of Alcala) — Principal investigator
First posted
Jun 5, 2026
Start date
Jun 8, 2026
Primary completion
Sep 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Jul 1, 2026

Study contacts

Daniel Pecos-Martin, PhD
Contact
daniel.pecos@uah.es
34918855142

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion